triptolide has been researched along with Triple Negative Breast Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, Z; Ma, X; Ni, R; Pan, Y; Wu, Q; Yang, G | 1 |
| Cai, J; Cheng, H; Xu, J; Xu, S; Zhong, M | 1 |
| Ai, L; Deng, Z; He, J; Peng, T; Peng, Y; Tan, W; Wang, XQ | 1 |
| Ethier, SP; Qin, S; Schulte, BA; Tew, KD; Wang, GY; Yang, A | 1 |
| Cao, X; Chi, X; Gao, X; Ji, J; Liu, L; Mao, W; Sun, C; Wang, Y; Yang, Y; Zhang, L; Zhang, Z; Zhao, Z | 1 |
5 other study(ies) available for triptolide and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Zhuidu Formula suppresses the migratory and invasive properties of triple-negative breast cancer cells via dual signaling pathways of RhoA/ROCK and CDC42/MRCK.
Topics: Actins; Animals; Cell Adhesion; Cell Growth Processes; Cell Movement; Cytoskeleton; Disease Models, Animal; Drug Synergism; Ethnopharmacology; Female; Humans; Matrix Metalloproteinases; MDA-MB-231 Cells; Medicine, Chinese Traditional; Mice; Myotonin-Protein Kinase; Neoplasm Invasiveness; Neoplasm Metastasis; Paclitaxel; rho-Associated Kinases; Signal Transduction; Triple Negative Breast Neoplasms | 2023 |
Codelivery of triptolide and IFN-γ to boost antitumor immunity for triple-negative breast cancer.
Topics: Antineoplastic Agents; B7-H1 Antigen; Diterpenes; Humans; Interferon-gamma; Triple Negative Breast Neoplasms; Tumor Microenvironment | 2023 |
Molecularly Engineering Triptolide with Aptamers for High Specificity and Cytotoxicity for Triple-Negative Breast Cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aptamers, Nucleotide; Cell Line, Tumor; Cell Proliferation; Diterpenes; Epoxy Compounds; Female; Humans; Mice; Phenanthrenes; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2020 |
MYC Inhibition Depletes Cancer Stem-like Cells in Triple-Negative Breast Cancer.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Diterpenes; Drug Resistance, Neoplasm; Epoxy Compounds; Female; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Phenanthrenes; Proto-Oncogene Proteins c-myc; RNA Interference; RNA, Small Interfering; Spheroids, Cellular; Triple Negative Breast Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2017 |
Triptolide interferes with XRCC1/PARP1-mediated DNA repair and confers sensitization of triple-negative breast cancer cells to cisplatin.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cisplatin; Diterpenes; DNA Damage; DNA Repair; Epoxy Compounds; Female; Gene Expression Regulation, Neoplastic; Humans; Phenanthrenes; Poly (ADP-Ribose) Polymerase-1; Triple Negative Breast Neoplasms; X-ray Repair Cross Complementing Protein 1 | 2019 |